NOW AVAILABLEInvestment opportunity Boataround. Learn more.

MultiplexDX 2023

Revolutionary Multiplex8+ diagnostics enables personalized cancer treatment

SK
CompaniesEquityFunded
Equity

Closure

About the investment opportunity

Multiplex8+ diagnostic test

Register and get access to details
Already have an account? Log in

We are a regulated entity. Campaign details can only be viewed by registered users.

Register and get access to details
Already have an account? Log in

We are a regulated entity. Campaign details can only be viewed by registered users.

MultiplexDX at a glance

Register and get access to details
Already have an account? Log in

We are a regulated entity. Campaign details can only be viewed by registered users.

The company and its goals

Register and get access to details
Already have an account? Log in

We are a regulated entity. Campaign details can only be viewed by registered users.

For more detailed information on the market analysis and competitive environment, please refer to the investment information that follows the non-binding expression of interest.
More information

Media

€7,500,000
Target amount
161
Investors
30%+ p.a.
Required return

Become a MultiplexDX co-owner today.

Existing investors are offering their shares via secondary trading.

View current listings
Our Portfolio team is here to help.

For questions about your investments, write to portfolio@crowdberry.eu.